Correlation Between Cyxone AB and Kancera AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cyxone AB and Kancera AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyxone AB and Kancera AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyxone AB and Kancera AB, you can compare the effects of market volatilities on Cyxone AB and Kancera AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyxone AB with a short position of Kancera AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyxone AB and Kancera AB.

Diversification Opportunities for Cyxone AB and Kancera AB

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Cyxone and Kancera is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Cyxone AB and Kancera AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kancera AB and Cyxone AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyxone AB are associated (or correlated) with Kancera AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kancera AB has no effect on the direction of Cyxone AB i.e., Cyxone AB and Kancera AB go up and down completely randomly.

Pair Corralation between Cyxone AB and Kancera AB

Assuming the 90 days trading horizon Cyxone AB is expected to generate 1.71 times more return on investment than Kancera AB. However, Cyxone AB is 1.71 times more volatile than Kancera AB. It trades about 0.01 of its potential returns per unit of risk. Kancera AB is currently generating about -0.11 per unit of risk. If you would invest  3.90  in Cyxone AB on August 29, 2024 and sell it today you would lose (1.35) from holding Cyxone AB or give up 34.62% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Cyxone AB  vs.  Kancera AB

 Performance 
       Timeline  
Cyxone AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cyxone AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Cyxone AB is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Kancera AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kancera AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Cyxone AB and Kancera AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cyxone AB and Kancera AB

The main advantage of trading using opposite Cyxone AB and Kancera AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyxone AB position performs unexpectedly, Kancera AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kancera AB will offset losses from the drop in Kancera AB's long position.
The idea behind Cyxone AB and Kancera AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bonds Directory
Find actively traded corporate debentures issued by US companies
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency